The Effect Of Return On Assets (Roa) And Return On Equity (Roe) Towards Changes In Share Prices
Main Article Content
Abstract
This study aims to test and prove the effect of Return On Assets (ROA) and Return On Equity (ROE) on share prices in the pharmaceutical industry listed on the IDX. The population in the study of pharmaceutical companies listed on the IDX in the 2015-2019 period and the sample used were 6 pharmaceutical companies with a purposive sampling technique. The results of this study indicate that partially ROA has no effect on share prices. In addition, ROE also partially has no effect on share prices. And simultaneously ROA and ROE have no effect on share prices in pharmaceutical companies listed on the IDX in the 2015-2019 period.
Downloads
Metrics
Article Details
Licensing
TURCOMAT publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.